ADRO: Aduro Biotech, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 119.16
Enterprise Value ($M) 59.92
Book Value ($M) 82.05
Book Value / Share 1.02
Price / Book 1.38
NCAV ($M) 4.55
NCAV / Share 0.06
Price / NCAV 24.96

Profitability (mra)
Return on Invested Capital (ROIC) -0.70
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 7.26

Balance Sheet (mrq) ($M)
Current Assets 235.81
Assets 313.31
Liabilities 231.27
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -101.36
Net Income -95.36
Earnings Per Share Basic And Diluted -1.21
Earnings Per Share Diluted -1.21
Earnings Per Share Basic -1.21

Cash Flow Statement (mra) ($M)
Cash From Operations -68.76
Cash from Investing 39.41
Cash from Financing 39.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-01-17 13G/A Singer James R 4.00 -24.85
2019-05-24 13D/A Morningside Venture (VI) Investments Ltd 18.63 0.00
2019-02-11 13G/A Wellington Management Group LLP 0.00 -100.00
2019-02-08 13G BlackRock Inc. 6.70 0.00
2019-02-08 13G/A Harvard Management Co Inc 0.81 -84.65
2019-01-22 13G/A Johnson & Johnson 4.90 0.00
2017-12-19 13G/A Novartis Ag 4.10 0.00
2017-02-14 13G/A FMR LLC / Fidelity 4.24 -53.19

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-07 10-Q ADRO / Aduro Biotech, Inc. 10-Q – Quarterly Report – 10-Q
2019-08-01 10-Q ADRO / Aduro Biotech, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-07 10-Q ADRO / Aduro Biotech, Inc. 10-Q Quarterly Report 10-Q
2019-02-27 10-K ADRO / Aduro Biotech, Inc. 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-01-22 458,822 1,248,700 36.74
2020-01-21 218,124 834,700 26.13

(click for more detail)

Similar Companies
ADMA – ADMA Biologics Inc ADMP – Adamis Pharmaceuticals Corp.
ADMS – Adamas Pharmaceuticals, Inc. ADVM – Adverum Biotechnologies, Inc.
ADXS – Advaxis, Inc.


Financial data and stock pages provided by
Fintel.io